Literature DB >> 5017368

Human heterophil antibodies against rat erythrocytes. II. Cross reactivity with human A and B substances.

T S Tiong, P J Morris.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 5017368      PMCID: PMC1713093     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


× No keyword cloud information.
  6 in total

1.  Human heterophil antibodies against rat erythrocytes. I. Changes after renal transplantation.

Authors:  T S Tiong; P J Morris
Journal:  Clin Exp Immunol       Date:  1972-01       Impact factor: 4.330

2.  Antibody production in immunosuppressed recipients of renal allografts.

Authors:  M J Rowley; I R Mackay; I F McKenzie
Journal:  Lancet       Date:  1969-10-04       Impact factor: 79.321

3.  IgM activity in human lymphotoxic antisera after renal transplantation.

Authors:  J W Stocker; I F McKenzie; P J Morris
Journal:  Nature       Date:  1969-05-03       Impact factor: 49.962

4.  Heterophile antibodies in human transplantation.

Authors:  F T Rapaport; K Kano; F Milgrom
Journal:  J Clin Invest       Date:  1968-03       Impact factor: 14.808

5.  Studies on a naturally occurring human antibody active against mouse Landschutz ascites tumor cells. I. Cytotoxicity assay system and quantitation in normal sera.

Authors:  R Laskov; E Simon; J Gross
Journal:  Int J Cancer       Date:  1968-01-15       Impact factor: 7.396

6.  Heterophilic antibodies following injection of blood group substances.

Authors:  I Davidsohn; C L Lee
Journal:  Transfusion       Date:  1966 Sep-Oct       Impact factor: 3.157

  6 in total
  2 in total

1.  Occurrence and cross-reactivity of heterophile antibodies and anti-kidney antibodies in kidney transplanted patients and patients with renal disease.

Authors:  S E Svehag; R Olander; K G Sundqvist
Journal:  Clin Exp Immunol       Date:  1973-02       Impact factor: 4.330

2.  Human heterophil antibodies against rat erythrocytes. I. Changes after renal transplantation.

Authors:  T S Tiong; P J Morris
Journal:  Clin Exp Immunol       Date:  1972-01       Impact factor: 4.330

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.